相关实验视频
Updated: Jan 15, 2026

08:04
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
1.4K
CCL21通过CCR7激活增强了血小板激活和动脉血症
Xin Liu1, Peng Zhang1,2, Zhexun Lian1
1Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (X.L., P.Z., Z.L., H.Y., Y.L., J. Guo, N.Z.).
Circulation research
|October 10, 2025
概括
化学因子CCL21 (C-C动机化学因子连接体21) 在冠状动脉疾病中促进血小板激活和血栓形成. 一个CCL21抗体为这些血栓性并发症提供了潜在的治疗益处.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 恒常化基因CCL21 (C-C动机化基因联接体21) 在冠状动脉疾病 (CAD) 中升高.
- 血CCL21升高与急性冠状动脉综合征后不良结果有关.
- CCL21在CAD相关的血小板激活和血栓形成中的确切作用尚不清楚.
研究的目的:
- 为了研究CCL21对血小板功能和血栓形成的影响.
- 阐明CCL21介导的血小板激活背后的分子机制.
- 评估CCL21抗体在CAD和动脉样硬化中的治疗潜力.
主要方法:
- 评估了CCL21对血小板激活的影响 (聚合,颗粒释放,P-选择素/整合素激活,扩散,凝块收缩).
- 评估了CCL21在体外和体内血栓形成模型中的作用,包括中脑动脉封闭和心肌缺血-再输血损伤.
- 研究了CCL21与血小板CCR7的结合以及下游的Gi/G13信号.
- 在CAD患者和动脉样硬化小鼠中测试了CCL21抗体的疗效.
主要成果:
- CCL21显著增强了激素诱导的血小板激活,并在体内增强了血栓形成.
- CCL21与血小板CCR7 (C-C动机化学因子受体7) 结合,激活Gi和G13通路.
- 一个CCL21抗体降低了血小板激活,并在CAD患者和动脉样硬化小鼠中抑制了血栓形成.
- 该抗体还减轻了微血管血栓形成,并保护了心脏免受缺血-再输血损伤.
结论:
- CCL21通过CCR7,Gi和G13信号增强了血小板激活和动脉动血栓形成.
- 一种CCL21抗体显示出作为预防CAD中血栓性并发症的治疗潜力.
更多相关视频
相关概念视频
Formation of the Platelet Plug
8.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Structure and Function of Platelets
2.9K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.9K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Coronary Artery Disease II: Pathophysiology
367
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
367
Intracellular Signaling Affects Focal Adhesions
3.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.5K

